These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 822408)

  • 21. Effect of dihydroergotoxine (Hydergine) and phenothiazines on conditioned avoidance reflexes and body temperature of the rat.
    Bálint G; Anokbonggo WW
    Acta Physiol Acad Sci Hung; 1968; 33(1):95-8. PubMed ID: 4968607
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 23. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin].
    Radielović P
    Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.
    Mongeau B
    Eur J Clin Pharmacol; 1974; 7(3):169-75. PubMed ID: 4212405
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of ergot alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys.
    Szewczykowski J; Meyer JS; Kondo A; Nomura F; Teraura T
    J Neurol Sci; 1970 Jan; 10(1):25-31. PubMed ID: 4983718
    [No Abstract]   [Full Text] [Related]  

  • 28. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of dihydroergotoxin and phentolamine on the alpha--adrenoreceptors of the vessels of the kidney and intestines].
    Buianov VV
    Farmakol Toksikol; 1974; 37(6):674-6. PubMed ID: 4219191
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
    Borenstein P; Cujo P; Bahon L
    Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
    [No Abstract]   [Full Text] [Related]  

  • 32. The action of ergot alkaloids (ergotamine and dihydroergotoxin) on the functional effects of cerebral ischemia in the cat.
    Boismare F; Streichenberger G
    Pharmacology; 1974; 12(3):152-9. PubMed ID: 4216904
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacodynamics of the cerebral circulation. Angiographic study].
    Cappellini M; De Marzi S
    Nunt Radiol; 1967 Nov; 33(11):1343-62. PubMed ID: 4977950
    [No Abstract]   [Full Text] [Related]  

  • 34. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of some drugs used for cerebral vascular insufficiency on somesthesic primary potentials evoked at the level of cortex and thalamus in the cat in a state of acute cerebral ischemia].
    Rossignol P; Boulu R; Ribart M; Paultre C; Bache S; Truelle B
    C R Acad Hebd Seances Acad Sci D; 1972 May; 274(22):3027-9. PubMed ID: 4626346
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mental effects of Wallerox therapy in the aged].
    Thomae H
    Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of different vasoactive drugs on subcortical irrigation in rabbits and dogs].
    Pourrias B; Raynaud G
    Therapie; 1972; 27(5):849-60. PubMed ID: 4631270
    [No Abstract]   [Full Text] [Related]  

  • 40. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.